No phaseEnrolling by invitation
Clinical Alternatives for Reducing Harm Using E-cigarettes (CARE)
A Novel Harm Reduction Approach for Oncology Outpatients Who Smoke and Refuse Traditional Tobacco Treatment
- Sponsor
- Medical University of South Carolina (Academic or other)
- Enrolment
- 208 planned
- Conditions
- Smoking; E-Cig Use; Oncology
- Interventions
- Harm Reduction (E-cigarette switching); Standard of Care
- Ages
- adults, older adults
- Registry
- NCT07039292
Full record on ClinicalTrials.gov
From the registry
For patients in cancer care, quitting smoking is critical, but a significant portion of patients in cancer care refuse all components of tobacco treatment, even when offered free of charge. The proposed clinical trial will assess one harm reduction intervention, switching completely from cigarettes to e-cigarettes, among oncology outpatients who smoke and refuse traditional tobacco treatment. This study is a type 1 hybrid effectiveness-implementation trial among oncology outpatients at an NCI-designated cancer center who smoke and refuse all components of tobacco treatment (N=208).
Primary outcomes
- Complete switching
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered